{"id":177702,"date":"2018-01-16T11:21:05","date_gmt":"2018-01-16T11:21:05","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=177702"},"modified":"2018-01-16T11:21:05","modified_gmt":"2018-01-16T11:21:05","slug":"cancer-immunotherapy-market-2018-technological-advancements-recent-trends-and-development-and-forecasts-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cancer-immunotherapy-market-2018-technological-advancements-recent-trends-and-development-and-forecasts-to-2023_177702.html","title":{"rendered":"Cancer Immunotherapy Market 2018 Technological Advancements | Recent Trends and Development and Forecasts To 2023"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Cancer Immunotherapy Market”<\/div>\n<\/div>\n<\/div>\n
Global Cancer Immunotherapy Market was USD 36.8 Billion in 2016 which is expected to grow at a healthy CAGR of 14.8% and reach till USD 101.6 billion by 2023. On the basis of application, it is segmented into liver cancer, childhood cancer, colorectal cancer, stomach cancer, lung cancer and others.<\/div>\n

The Global Cancer Immunotherapy Market has been growing at an impressive rate in recent years and will maintain the same in coming future. Approximately 100 different types of cancer have been identified. Cancer is condition of uncontrolled cell growth. The Cancer Immunotherapy Market<\/a><\/strong>, on the other hand, helps the immune system to target cancerous tumor cells, which is in fact the natural tendency of the body but tends to weaken with the advent of disease infections. According to W.H.O. cancer is the leading cause of the total number of deaths globally in 2015, and was responsible for 8.8 million deaths in 2015. Statistics suggest that nearly 1 in 6 patients die due to cancer. Due to deteriorating lifestyle, smoking, and alcoholism are responsible for increasing the incidence of cancer. Increasing cancer population is the major reason for increasing the global immunotherapy market. Many therapies are available in the market but the advantage of immunotherapy is its high effectiveness and less side effects as compared to other therapies. This therapy is effective for patients suffering from melanoma cancer when chemotherapy and other radiation therapies do not work.<\/span><\/em><\/p>\n

Cancer Immunotherapy Market Key Players:<\/span><\/em><\/strong><\/p>\n

Some of key the players in the market are F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, GlaxoSmithKline Plc., Amgen Inc., Bristol-Myers Squibb, ELI Lilly and Company, Celgene Corporation, Seattle Genetics, Inc., Spectrum Pharmaceuticals, Inc.<\/span><\/em><\/p>\n

Receive Exclusive Sample Report @ <\/span><\/em><\/strong>https:\/\/www.marketresearchfuture.com\/sample_request\/567<\/a> .<\/span><\/em><\/p>\n

Cancer Immunotherapy Market Regional Analysis<\/span><\/em><\/strong><\/p>\n

Global cancer immunotherapy market is segmented into four main geographical region, they are North America, Europe, Asia Pacific and The Middle East and Africa. <\/span><\/em><\/p>\n

Over the last few years, North America and Europe are the major contributors in the global cancer immunotherapy market. Due to their reputation as a suitable place for research and development. The market for cancer immunotherapy has a huge demand in both region and is expected to grow in coming future.<\/span><\/em><\/p>\n

Asia Pacific is however the fastest growing cancer immunotherapy market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover increasing demand for new treatment methods in countries like India and South Korea are likely to emerge as the fastest growing market across the globe.<\/span><\/em><\/p>\n

The Middle East and Africa holding the least growth in comparison to other region, although, increasing occurrence of cancer owing to smoking, change in lifestyle, and excessive alcohol intake are driving the cancer immunotherapy market in this region<\/span><\/em><\/p>\n

Cancer Immunotherapy Market Segmentations:<\/span><\/em><\/strong><\/p>\n

The Global Cancer Immunotherapy Market is segmented on the basis of therapy types, by application, by end user.<\/span><\/em><\/p>\n

On the basis of type, it is segmented into monoclonal antibodies, adoptive cell transfer, cytokines, treatment vaccines, bacillus calmette-guérin, and others. Monoclonal antibodies segment is further segmented into naked monoclonal antibodies, conjugated monoclonal antibodies, and bispecific monoclonal antibodies. Cytokines are further segmented into Interferon, Interleukins<\/span><\/em><\/p>\n

On the basis of application, it is segmented into liver cancer, childhood cancer, colorectal cancer, stomach cancer, lung cancer and others.<\/span><\/em><\/p>\n

On the basis of end user, it is segmented into hospitals, clinics, and others.<\/span><\/em><\/p>\n

Browse Complete Premium 85 Pages Half Cooked Research Report Enabled with Respective Tables and Figures is Available @ <\/span><\/em><\/strong>https:\/\/www.marketresearchfuture.com\/checkout?currency=one_user-USD&report_id=567<\/a> .<\/span><\/em><\/p>\n

Major TOC for Cancer Immunotherapy Market:<\/span><\/em><\/strong><\/p>\n

Table of Contents<\/span><\/em><\/strong><\/p>\n

    \n
  1.  Report Prologue<\/span><\/em><\/strong>\n

    2.    Market Introduction    <\/span><\/span><\/em><\/strong><\/p>\n

          2.1    Definition<\/p>\n

          2.2    Scope of the Study<\/p>\n

                2.2.1    Research Objective<\/p>\n

                2.2.2    Assumptions<\/p>\n

                2.2.3    Limitations<\/p>\n

    3.    Research Methodology<\/span><\/strong><\/p>\n

          3.1    Introduction<\/p>\n

          3.2    Primary Research<\/p>\n

          3.3    Secondary research<\/p>\n

          3.4    Market Size Estimation<\/p>\n

    <\/span><\/em>….Continued<\/span><\/em><\/strong><\/li>\n<\/ol>\n

    Ask Questions to Expertise @ <\/span><\/em><\/strong>https:\/\/www.marketresearchfuture.com\/enquiry\/567<\/a><\/span><\/em> .<\/span><\/em><\/p>\n

    About US:<\/span><\/em><\/strong><\/p>\n

    Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/span><\/em><\/p>\n

    Media Contact<\/span>
    Company Name:<\/strong> Market Research Future
    Contact Person:<\/strong> Akash Anand
    Email:<\/strong> akash.anand@marketresearchfuture.com
    Phone:<\/strong> +1 646 845 9312
    Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
    City:<\/strong> Pune
    State:<\/strong> Maharashtra
    Country:<\/strong> India
    Website:<\/strong>     https:\/\/www.marketresearchfuture.com\/reports\/global-cancer-immunotherapy-market-567<\/a><\/p>\n

    <\/object><\/p>\n

    \"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

    “Cancer Immunotherapy Market” Global Cancer Immunotherapy Market was USD 36.8 Billion in 2016 which is expected to grow at a healthy CAGR of 14.8% and reach till USD 101.6 billion by 2023. On the basis of application, it is segmented … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-177702","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/177702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=177702"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/177702\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=177702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=177702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=177702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}